Envista (NYSE:NVST) Price Target Raised to $26.00

Envista (NYSE:NVST) had its price objective boosted by Wells Fargo & Company from $21.00 to $26.00 in a research note published on Friday,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other research analysts have also recently commented on NVST. William Blair upgraded shares of Envista from a “hold” rating to an “outperform” rating in a research note on Friday. Robert W. Baird set a $27.00 target price on Envista in a report on Friday, October 31st. Stifel Nicolaus set a $31.00 price target on Envista in a research note on Friday. Barclays initiated coverage on Envista in a research report on Monday, December 8th. They issued an “overweight” rating and a $24.00 price target on the stock. Finally, Leerink Partners set a $35.00 price objective on Envista and gave the company an “outperform” rating in a report on Friday. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $26.50.

Envista Stock Up 18.0%

NVST opened at $29.17 on Friday. The company has a market capitalization of $4.80 billion, a P/E ratio of 104.18, a P/E/G ratio of 1.20 and a beta of 1.01. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.38 and a quick ratio of 2.04. The firm’s fifty day moving average price is $22.80 and its two-hundred day moving average price is $21.24. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $29.28.

Envista (NYSE:NVST) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The company had revenue of $750.60 million during the quarter, compared to analysts’ expectations of $680.26 million. During the same quarter in the prior year, the company posted $0.24 EPS. The business’s revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts anticipate that Envista will post 1 EPS for the current year.

Institutional Trading of Envista

Large investors have recently made changes to their positions in the business. Royal Bank of Canada raised its holdings in shares of Envista by 26.6% in the first quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after buying an additional 4,885 shares during the last quarter. Millennium Management LLC increased its position in Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after acquiring an additional 263,442 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Envista by 39.3% in the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock worth $10,859,000 after acquiring an additional 177,630 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Envista by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock worth $9,821,000 after acquiring an additional 76,246 shares during the last quarter. Finally, KLP Kapitalforvaltning AS lifted its position in shares of Envista by 11.3% during the second quarter. KLP Kapitalforvaltning AS now owns 36,400 shares of the company’s stock worth $711,000 after purchasing an additional 3,700 shares in the last quarter.

Key Stories Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q4 results beat expectations — Envista reported $0.38 EPS vs. $0.32 consensus and revenue of $750.6M versus ~ $680M est., with revenue up ~15% year-over-year. Strong results are the primary driver of the move higher. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Management raised FY‑2026 EPS guidance to $1.35–$1.45 vs. consensus ~ $1.27 — the stronger outlook (and beat + guidance combo) is supportive of the rally and suggests better-than-expected near-term growth. Press Release / Slide Deck
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read — the conference call transcript and slide deck provide management commentary on drivers (product mix, geographic trends, margins) that investors should review to judge sustainability. Earnings Call Transcript Earnings Presentation
• Neutral Sentiment: Wall‑street writeups and snapshots (Zacks, Yahoo, Investing) highlight the beat and value/Growth characteristics — useful for screening but not new catalysts by themselves. Zacks Q4 Metrics
• Negative Sentiment: Analyst targets still imply downside — JPMorgan and Wells Fargo both raised targets to $26 but kept neutral/equal‑weight ratings; those $26 targets sit below the current market level, which could cap upside or prompt caution once headline momentum fades. Benzinga – JPMorgan Benzinga – Wells Fargo

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.